Early outcomes of migraine after erenumab discontinuation: data from a real-life setting
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early outcomes of migraine after erenumab discontinuation: data from a real-life setting
Authors
Keywords
-
Journal
NEUROLOGICAL SCIENCES
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-03
DOI
10.1007/s10072-020-05022-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives
- (2020) Eleonora De Matteis et al. Expert Review of Neurotherapeutics
- Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
- (2020) Raffaele Ornello et al. JOURNAL OF HEADACHE AND PAIN
- Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2019) Valery L Feigin et al. LANCET NEUROLOGY
- CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
- (2019) Valentina Favoni et al. JOURNAL OF HEADACHE AND PAIN
- Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
- (2019) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)
- (2019) Paolo Martelletti et al. JOURNAL OF HEADACHE AND PAIN
- Erenumab and galcanezumab in chronic migraine prevention: effects after treatment termination
- (2019) Bianca Raffaelli et al. JOURNAL OF HEADACHE AND PAIN
- Monoclonal antibodies for the prevention of migraine
- (2019) Bianca Raffaelli et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- CGRP as the target of new migraine therapies — successful translation from bench to clinic
- (2018) Lars Edvinsson et al. Nature Reviews Neurology
- Chronic migraine: risk factors, mechanisms and treatment
- (2016) Arne May et al. Nature Reviews Neurology
- The therapeutic armamentarium in migraine is quite elderly
- (2014) Paolo Martelletti Expert Opinion on Drug Metabolism & Toxicology
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
- (2014) Erik von Elm et al. International Journal of Surgery
- Migraine prevalence by age and sex in the United States: A life-span study
- (2010) TW Victor et al. CEPHALALGIA
- Prevalence of headache in Europe: a review for the Eurolight project
- (2010) Lars Jacob Stovner et al. JOURNAL OF HEADACHE AND PAIN
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started